Abstract：
OBJECTIVE: The purpose of this study is to elicit the amount of safety margin necessary around the ameloblastic lesion in view of preventing further recurrence.
METHODS: The study consisted of 25 cases of mandibular ameloblastoma. Diagnosis was based on clinical and radiological analysis and confirmed by histopathological report. An incisional biopsy was done preoperatively to confirm the diagnosis. Segmental resection was planned for all the cases. After the resection, postoperative panoramic radiograph of the specimen was taken followed by histopathological examination of its margin to detect tumor cell infiltration.
CONCLUSIONS: In all our cases, the ameloblastoma was infiltrating in nature. A follow-up period of 10 years showed neither recurrence nor implant failure. In our study, we conclude our safe margin for infiltrating variant of ameloblastoma based on histopathological report of the resected specimen.
METHODS: The study consisted of 25 cases of mandibular ameloblastoma. Diagnosis was based on clinical and radiological analysis and confirmed by histopathological report. An incisional biopsy was done preoperatively to confirm the diagnosis. Segmental resection was planned for all the cases. After the resection, postoperative panoramic radiograph of the specimen was taken followed by histopathological examination of its margin to detect tumor cell infiltration.
CONCLUSIONS: In all our cases, the ameloblastoma was infiltrating in nature. A follow-up period of 10 years showed neither recurrence nor implant failure. In our study, we conclude our safe margin for infiltrating variant of ameloblastoma based on histopathological report of the resected specimen.
摘要：
目的：这项研究的目的是在成釉细胞病变周围引起必要的安全界限，以防止进一步复发。
方法：本研究包括25例下颌骨成釉细胞瘤。诊断基于临床和放射学分析，并通过组织病理学报告证实。术前进行了切开活检以确认诊断。计划对所有病例进行分段切除。切除后,术后对标本进行全景X线片，然后对其边缘进行组织病理学检查以检测肿瘤细胞浸润。
结论：在我们所有的案例中，成釉细胞瘤本质上是浸润的。10年的随访期显示既没有复发也没有植入失败。在我们的研究中,我们根据切除标本的组织病理学报告得出我们对于成釉细胞瘤浸润性变异型的安全界限.
方法：本研究包括25例下颌骨成釉细胞瘤。诊断基于临床和放射学分析，并通过组织病理学报告证实。术前进行了切开活检以确认诊断。计划对所有病例进行分段切除。切除后,术后对标本进行全景X线片，然后对其边缘进行组织病理学检查以检测肿瘤细胞浸润。
结论：在我们所有的案例中，成釉细胞瘤本质上是浸润的。10年的随访期显示既没有复发也没有植入失败。在我们的研究中,我们根据切除标本的组织病理学报告得出我们对于成釉细胞瘤浸润性变异型的安全界限.
